|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127.52 EUR | +1.05% |
|
+2.03% | +4.49% |
| 14/02 | Health Care Up Amid Mixed Earnings - Health Care Roundup | DJ |
| 13/02 | Sanofi's new CEO needs to fix drug pipeline and navigate Trump | RE |
| Capitalization | 5.49TCr 6.5TCr 5.01TCr 4.77TCr 8.86TCr 5,90600Cr 9.2TCr 58TCr 23TCr 2,84300Cr 24TCr 24TCr 9,98300Cr | P/E ratio 2025 * |
19.3x | P/E ratio 2026 * | 19.3x |
|---|---|---|---|---|---|
| Enterprise value | 6.29TCr 7.46TCr 5.74TCr 5.47TCr 10TCr 6,77300Cr 11TCr 67TCr 27TCr 3,26100Cr 28TCr 27TCr 11,45000Cr | EV / Sales 2025 * |
2.97x | EV / Sales 2026 * | 2.86x |
| Free-Float |
29.72% | Yield 2025 * |
1.84% | Yield 2026 * | 1.91% |
Last Transcript: Merck KGaA
| 1 day | +1.19% | ||
| 1 week | +2.03% | ||
| Current month | +2.03% | ||
| 1 month | -0.77% | ||
| 3 months | +10.67% | ||
| 6 months | +15.67% | ||
| Current year | +4.49% |
| 1 week | 123.85 | 128.9 | |
| 1 month | 119.85 | 129.45 | |
| Current year | 119.85 | 131.65 | |
| 1 year | 100.7 | 142.45 | |
| 3 years | 100.7 | 186.4 | |
| 5 years | 100.7 | 231.5 | |
| 10 years | 71.15 | 231.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 01/05/2021 | |
| Director of Finance/CFO | 55 | 01/07/2023 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | 26/04/2019 |
Jürgen Glaser
BRD | Director/Board Member | 63 | 01/05/2012 |
| Director/Board Member | 77 | 09/05/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.05% | +2.03% | -5.43% | -30.17% | 6.5TCr | ||
| +1.50% | +1.06% | +40.02% | +62.04% | 934.19Cr | ||
| +0.46% | +9.87% | +26.04% | -12.23% | 884.06Cr | ||
| -3.70% | -0.46% | -13.06% | +60.59% | 592.88Cr | ||
| -0.55% | +1.40% | -13.03% | +120.54% | 560.31Cr | ||
| +1.47% | +4.39% | +222.52% | +83.83% | 431.74Cr | ||
| -2.42% | -1.42% | +417.08% | +952.90% | 305.87Cr | ||
| +1.10% | +0.57% | +29.48% | +30.97% | 291.51Cr | ||
| -2.59% | -2.84% | -10.41% | -23.46% | 279.31Cr | ||
| -1.38% | -0.79% | +30.78% | +23.85% | 246.79Cr | ||
| Average | -0.46% | +0.45% | +72.40% | +126.89% | 1.1TCr | |
| Weighted average by Cap. | +0.59% | +1.85% | +22.39% | +26.32% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.12TCr 2.51TCr 1.93TCr 1.84TCr 3.42TCr 2,28100Cr 3.55TCr 22TCr 8.93TCr 1,09800Cr 9.42TCr 9.23TCr 3,85500Cr | 2.13TCr 2.53TCr 1.94TCr 1.85TCr 3.44TCr 2,29300Cr 3.57TCr 23TCr 8.98TCr 1,10400Cr 9.47TCr 9.28TCr 3,87700Cr |
| Net income | 282.74Cr 335.15Cr 257.91Cr 245.88Cr 456.8Cr 30TCr 473.91Cr 3TCr 1.19TCr 15TCr 1.26TCr 1.23TCr 51TCr | 282.44Cr 334.81Cr 257.64Cr 245.62Cr 456.32Cr 30TCr 473.42Cr 2.99TCr 1.19TCr 15TCr 1.26TCr 1.23TCr 51TCr |
| Net Debt | 806.15Cr 955.61Cr 735.37Cr 701.05Cr 1.3TCr 87TCr 1.35TCr 8.54TCr 3.4TCr 42TCr 3.58TCr 3.51TCr 1,46700Cr | 601.84Cr 713.42Cr 549Cr 523.38Cr 972.36Cr 65TCr 1.01TCr 6.38TCr 2.54TCr 31TCr 2.68TCr 2.62TCr 1,09500Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | 128.25 € | +1.62% | 60,473 |
| 16/26/16 | 126.20 € | -1.25% | 1,42,446 |
| 13/26/13 | 127.80 € | +1.91% | 3,58,386 |
| 12/26/12 | 125.40 € | +0.04% | 2,57,242 |
| 11/26/11 | 125.35 € | -0.16% | 2,31,425 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MRK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















